1. Home
  2. TSSI vs ARMP Comparison

TSSI vs ARMP Comparison

Compare TSSI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TSS Inc.

TSSI

TSS Inc.

HOLD

Current Price

$14.64

Market Cap

315.9M

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.87

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSSI
ARMP
Founded
2004
N/A
Country
United States
United States
Employees
161
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
315.9M
295.5M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
TSSI
ARMP
Price
$14.64
$7.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$16.00
$15.00
AVG Volume (30 Days)
1.9M
63.8K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.67
N/A
P/E Ratio
$42.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.87
$1.74
52 Week High
$31.94
$14.98

Technical Indicators

Market Signals
Indicator
TSSI
ARMP
Relative Strength Index (RSI) 55.89 41.35
Support Level $14.03 $7.22
Resistance Level $16.66 $7.93
Average True Range (ATR) 1.07 0.81
MACD 0.35 0.04
Stochastic Oscillator 63.44 43.72

Price Performance

Historical Comparison
TSSI
ARMP

About TSSI TSS Inc.

TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: